Protagenic Therapeutics, Inc. announced that at the Annual Meeting of Stockholders held on November 23, 2022 approved the election of Timothy R. Wright as a Class I director to serve their terms until the Company's 2025 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | -7.08% | +2.46% | +26.26% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.26% | 5.54M | |
+26.69% | 49.18B | |
+0.62% | 42.11B | |
+50.52% | 40.37B | |
-5.26% | 28.85B | |
+12.69% | 26.09B | |
-21.81% | 18.71B | |
+9.10% | 13.26B | |
+31.00% | 12.32B | |
-0.61% | 11.99B |
- Stock Market
- Equities
- PTIX Stock
- News Protagenic Therapeutics, Inc.
- Protagenic Therapeutics, Inc. Appoints Timothy R. Wright as a Class I Director